61 results about "Aromatase" patented technology

Drugs and cosmetics which are highly safe, and which are effective in preventing, improving, or treating various pathological conditions caused by estrogen depletion are provided. Provided are aromatase activators containing at least one member selected from plants such as Labiatae sps. including Isodon, Scutellaria (huangcen), Schizonepeta (jingjie), sage, lavender, Lamium album, and thyme, an extract thereof; yeast extract; silk protein extract; milk protein; trehalose; natto extract; royal jelly; oryza oil; hydrolyzated wheat extract; shea butter; and rice fermentation extract.

Disclosed is a cell activator, a collagen production promoter, a skin whitening agent, an antioxidant agent, an antiinflammatory agent, an aromatase activity promoter, a protease activity promoter, an external preparation for the skin, or a food which comprises an extract of Hibiscus makinoi.

A method for identifying an endocrine disrupter using a cell line having aromatase activity, particularly, a human granulosa-like tumor cell line; and a kit for carrying out the method is disclosed.

The present invention provides a medicine compound including the following raw materials with the weight portions such as 18 to 30 portions of prepared rehmannia rhizome, 9 to 12 portions of cornus dogwood fruit, 8 to 16 portions of Chinese yam, 9 to 12 portions of medlar, 8 to 16 portions of field dodder and 8 to 16 portions of deerhorn glue, and the purpose in preparing the medicine for delaying vaginal aging. The medicine is an active medicine for strengthening external gonad tissue aromatase and a medicine for increasing vaginal blood supply. The medicine is a medicine for preventing or / and curing senile vaginitis. Under a specific diagnosis standard, the medicine provided by the present invention has definite efficacy. The medicine has the advantages of same efficacy on delaying vaginal aging, few raw materials, wide sources, effective cost saving due to selection of raw materials, no effect on the level of serum estrogen after long-term administration, no proliferation on endometrium and safety. The present invention provides a new choice for clinically curing senile vaginitis, in particular preventing senile vaginitis or recurrence of senile vaginitis.

The invention relates to a composition for treating prostatic diseases and a preparation method thereof. The composition comprises the following components in parts by mass: 30 to 50 parts of theaflavin, 15 to 25 parts of herba dianthi superbi and 5 to 15 parts of herba dianthi chinensis. The preparation method comprises the following steps: S1: selecting materials; S2: adding the materials; S3: mixing powder; S4: mixing the powder again. The composition provided by the invention can be used for treating prostatic chronic inflammations and is used for treating diseases including prostatic hyperplasia, frequent micturition, dysuria, urgent urination, incomplete micturition, unsmooth and discontinuous micturition, urine leakage, heavy urine odor, micturition difficulty, hematuresis and the like; the composition has the effects of inhibiting the generation of DHT (Double Hydrogen Testosterone), balancing hormone in bodies, inhibiting aromatase, cleaning free radicals and reducing combination of sex hormone and protein.